REGN
REGENERON PHARMACEUTICALS, INC.
NASDAQ · Healthcare · Biotechnology · US
$784.85
−0.58%Forward multiples
Based on analyst estimates
- P/E forward
- 12.96x
- P/E 2026E
- 14.39x
- P/E 2027E
- 12.81x
- P/E 2028E
- 11.46x
- P/S forward
- 4.47x
Trailing multiples
Trailing twelve months
- P/E TTM
- 18.74x
- PEG TTM
- 0.42x
- Price / book
- 2.55x
- Price / sales
- 5.20x
- Price / cash flow
- 18.19x
Enterprise value
- Enterprise value
- $74.8B
- EV / sales
- 4.81x
- EV / EBITDA
- 13.01x
- EV / EBIT
- 18.84x
- Market cap
- $80.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026